Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
185 Leser
Artikel bewerten:
(1)

The Insight Partners: Medical Imaging Market Revenue to Cross USD 33,002.52 million by 2028, COVID-19 Impact and Global Analysis by The Insight partners

PUNE, India, Oct. 1, 2021 /PRNewswire/ -- According to The Insight Partners study on "Medical Imaging Market to 2028 - Global Analysis and Forecast - by Product, End User, and Geography" the market was valued at US$ 23,901.88 million in 2020 and is projected to reach US$ 33,002.52 million by 2028; it is expected to grow at a CAGR of 4.3% during 2021-2028. A few key factors such as the rising demand for early diagnosis of diseases; broadening the scope of clinical applications; rapidly growing geriatric population and the rising prevalence of diseases associated with it; surging technological advancements in the diagnostic imaging industry; and increasing investments, funds, and grants by public-private organizations drive the market growth.

The_Insight_Partners_Logo

In 2020, North America dominated the global medical imaging market. A surge in medical imaging services in hospitals and clinics, an increase in diagnostic imaging procedures, high patient awareness about early disease diagnosis, good reimbursement scenarios, and significant spending in healthcare are among the major factors that bolster the market growth in North America. Furthermore, the rising elderly population, growing prevalence of chronic diseases, and the surging number of diagnostic and medical imaging centers in the region are expected to drive the growth of the North America medical imaging market during the forecast period.

Strategic Insights

Report Coverage

Details

Market Size Value in

US$ 23,901.88 Million in 2020

Market Size Value by

US$ 33,002.52 Million by 2028

Growth rate

CAGR of 4.3% from 2021-2028

Forecast Period

2021-2028

Base Year

2021

No. of Pages

166

No. Tables

57

No. of Charts & Figures

76

Historical data available

Yes

Segments covered

Product; End User , and Geography

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Get Exclusive Sample Pages of Medical Imaging Market at https://www.theinsightpartners.com/sample/TIPHE100000883/

The medical imaging market in Asia Pacific is anticipated to grow at the fastest rate during the forecast period. China, India, and Japan are major contributors to the market growth owing to a few factors such as the increasing aging population, rising chronic diseases prevalence, growing supportive government efforts, and growing medical imaging research. Additionally, growing investments by international market players in the regional market fuel the growth of the market in Asia Pacific.

Introduction of Technologically Advanced Systems

Medical imaging is an integral part of the diagnostic process. From ultrasounds to MRIs and CT scans, medical imaging is utilized to properly diagnose and treat diseases. The capabilities of medical imaging have advanced dramatically over the last two decades. Essential research and technological developments have resulted in significant improvements in medical imaging technology. This advancement is critical for accurate diagnosis and improved patient care. When combined with the power of IT and digital technologies, developments in medical imaging increase procedural efficiency in the delivery and execution of patient care. Medical imaging technology is one of the domains where artificial intelligence (AI) has aided in improving many parts of the healthcare industry. The AI solution in medical imaging is designed to assist radiologists who diagnose issues related to body parts, such as chest, abdomen, spine, and head. In 2020, DeepMind, a division of Google, got the CE mark for its AI solution technology, making it available to medical facilities across Europe. The company has developed an AI system that can diagnose over 50 eye problems using regular medical scans. The LOGIQ E10 radiology ultrasound system, which is integrated with AI to record data and reconstruct images swiftly, was unveiled by GE Healthcare in March 2021 as breakthrough medical imaging technology. Closed connectivity and advanced algorithms are used in the digital system to ensure 48 times more data flow and 10 times more processing power than earlier systems.

The COVID-19 outbreak pandemic has disturbed various trades and businesses across the world. Many cities were closed to control the spread of the novel coronavirus, which canceled treatments and doctor's appointments. Patients suffering from critical health disorders require physical distancing from others. Nonetheless, delays in the treatment of chronic disease are distressing. However, in the case of COVID-19, numerous firms in the US, such as Siemens Healthineers and General Electric Company, are taking the lead and using imaging techniques, such as CT scans and ultrasounds, to examine patients' lungs as a part of COVID-19 treatment. In addition, in the UK, the practice of cardiology, general imaging, musculoskeletal, OB/GYN, and obstetrics, and gynecology has evolved. Owing to the diversification of the medical workforce and the decision to focus on treating critically ill patients, rising COVID-19 cases have propelled the demand for quick illness detection and treatment in the market.

Download the Latest COVID-19 Analysis on Medical Imaging Market Growth Research Report at https://www.theinsightpartners.com/covid-analysis-sample/TIPHE100000883/

Medical Imaging Market: Segmental Overview

The medical imaging market, by product, is segmented into CT systems, X-ray systems, PET systems, MRI systems, ultrasound systems, and others. The X-ray segment held the largest share of the market in 2020 and is also anticipated to register the highest CAGR of 5.5% in the market during the forecast period. Medical X-rays are commonly utilized to provide images of internal human tissues and structures. Medical X-ray is an essential aspect of the healthcare system because it provides information that is required to make the best therapeutic decisions. Early detection and diagnosis can save patients' time and money and can prevent them from experiencing unnecessary pain and suffering. It also has the potential to lower the scope and cost of treatment. According to a significant body of studies, early diagnosis has been linked to measurable health benefits, such as high survival rates and cheap treatment costs.

Medical Imaging Market: Competition Landscape and Key Developments

Companies such as GE Healthcare, Siemens Healthineers, Canon Medical, Esaote, and Samsung have been implementing strategies for the growth of the company, which, in turn, have brought about various changes in the market. Companies are focusing on the expansion and diversification of their market presence and the acquisition of a new customer base, thereby tapping prevailing business opportunities.
In March 2021, GE Healthcare launched Vscan AirTM, a cutting-edge, wireless pocket-sized ultrasound. Vscan AirTM offers crystal clear image quality, whole-body scanning capabilities, and intuitive software in the palm of clinicians' hands.

Company Profiles

  • General Electric Company
  • Siemens AG
  • Koninklijke Philips N.V.
  • SHIMADZU CORPORATION
  • Hitachi, Ltd.
  • Canon Inc.
  • Hologic, Inc.
  • Carestream Health Inc.
  • ESAOTE SPA
  • Samsung Group

Order a Copy of Medical Imaging Market Shares, Strategies and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPHE100000883/

In January 2021, Esaote launched MyLab X8 Ultrasound System in Canada. Previously approved by FDA in the US, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies, and delivering superior image quality without compromising workflow or efficiency.

In May 2021, GE Healthcare acquired Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable personalized healthcare.

In April 2021, Carestream Health and Ziehm Imaging Americas announced distribution partnership. The partnership is aimed in the addition of a mobile C-arm into its growing innovative product portfolio and the increasing market reach of Carestream's mobile and fluoroscopic product offerings.

Browse Related Reports:

  • AI in Medical Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis
  • Adult Medical Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis
  • Mobile Imaging Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis
  • Medical Imaging Equipment Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

Sameer Joshi
E-mail:sales@theinsightpartners.com
Phone: +1-646-491-9876
More Research: https://www.openpr.com/news/archive/139407/The-Insight-Partners.html

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg

© 2021 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.